临床实践指南:COVID-19患者住院治疗建议
该指南由德国医学专业学会通过结构化共识流程制定,基于PubMed文献检索,针对COVID-19住院患者的管理提出推荐或声明。推荐根据年龄、合并症、呼吸频率和氧饱和度判断住院指征;未近期行PCR检测的入院患者应立即检测;尽管给氧仍存在低氧血症(SpO2<90%)、呼吸困难或高呼吸频率的COVID-19患者应收入重症监护。低氧性呼吸功能不全可尝试高流量氧疗或无创通气,严重低氧血症/高呼吸频率患者应插管行有创通气。存在额外危险因素(如肥胖、已知血栓形成倾向、重症监护治疗或D-二聚体升高)时,可考虑强化血栓栓塞预防。地塞米松治疗可降低重症或危重型COVID-19患者死亡率。
要点
- 尽管给氧仍存在低氧血症(SpO2<90%)、呼吸困难或高呼吸频率的COVID-19患者应收入重症监护。
- 低氧性呼吸功能不全可尝试高流量氧疗或无创通气;严重低氧血症/高呼吸频率患者应插管行有创通气。
- 地塞米松治疗可降低重症或危重型COVID-19患者的死亡率。
- 存在额外危险因素(如肥胖、已知血栓形成倾向、重症监护治疗或D-二聚体升高)时,可考虑强化血栓栓塞预防。
- 未近期行PCR检测的入院患者应立即检测;重要个人防护措施包括注意卫生和正确佩戴个人防护装备。
适用人群与场景
- 住院COVID-19患者,包括需判断住院指征、重症监护收入指征及呼吸支持方式的患者。
- 住院指征判断需考虑年龄、合并症、呼吸频率和氧饱和度。
- 存在额外危险因素(如肥胖、已知血栓形成倾向、重症监护治疗或D-二聚体升高)的患者可考虑强化血栓栓塞预防。
诊断标准与关键阈值
- 尽管给氧仍存在低氧血症(SpO2<90%)、呼吸困难或高呼吸频率的COVID-19患者应收入重症监护。
- 严重低氧血症/高呼吸频率患者应插管行有创通气。
- 未近期行PCR检测的入院患者应立即检测。
处置流程与药物剂量
- 低氧性呼吸功能不全可尝试高流量氧疗或无创通气。
- 严重低氧血症/高呼吸频率患者应插管行有创通气。
- 重症或危重型COVID-19患者使用地塞米松可降低死亡率。
- 存在额外危险因素(如肥胖、已知血栓形成倾向、重症监护治疗或D-二聚体升高)时,可考虑强化血栓栓塞预防。
- 重要个人防护措施包括注意卫生和正确佩戴个人防护装备。
红旗征与不能漏的情况
- 尽管给氧仍存在低氧血症(SpO2<90%)、呼吸困难或高呼吸频率,需收入重症监护。
- 严重低氧血症/高呼吸频率,需插管行有创通气。
研究设计与关键结果
- 指南通过结构化共识流程制定推荐或声明,文献检索在PubMed进行,检索词由作者确定。
- 推荐根据年龄、合并症、呼吸频率和氧饱和度判断住院指征。
- 推荐未近期行PCR检测的入院患者立即检测。
- 推荐尽管给氧仍存在低氧血症(SpO2<90%)、呼吸困难或高呼吸频率的COVID-19患者收入重症监护。
- 建议低氧性呼吸功能不全尝试高流量氧疗或无创通气,严重低氧血症/高呼吸频率患者应插管行有创通气。
- 存在额外危险因素(如肥胖、已知血栓形成倾向、重症监护治疗或D-二聚体升高)时,可考虑强化血栓栓塞预防。
- 地塞米松治疗可降低重症或危重型COVID-19患者死亡率。
- 主要治疗措施为维持充分氧合、药物预防血栓及重症病例使用地塞米松。
证据类型、等级与局限
- 证据类型:临床实践指南,通过结构化共识流程制定推荐或声明。
- 局限:原文未报告局限性
对床旁实践的改变
- 对尽管给氧仍存在低氧血症(SpO2<90%)、呼吸困难或高呼吸频率的COVID-19患者,应收入重症监护。
- 对低氧性呼吸功能不全患者可尝试高流量氧疗或无创通气;对严重低氧血症/高呼吸频率患者应插管行有创通气。
- 对重症或危重型COVID-19患者使用地塞米松可降低死亡率。
- 对存在额外危险因素(如肥胖、已知血栓形成倾向、重症监护治疗或D-二聚体升高)的患者可考虑强化血栓栓塞预防。
- 对未近期行PCR检测的入院患者应立即检测,并注意卫生和正确佩戴个人防护装备。
指南或共识出处
- 临床实践指南:COVID-19患者住院治疗建议(Dtsch Arztebl Int)
提炼说明
- 本条依据论文摘要整理;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Since identification of the first cases in December 2019, COVID-19, caused by the novel coronavirus SARS-CoV-2 (severe acute respiratory syndrome-coronavirus-2) has spread across the world, giving rise to a global pandemic.
METHODS: A literature search was carried out in PubMed, using search terms defined by the authors. Questions important for the management of patients with COVID-19 were identified and discussed, and recommendations or statements on these topics were formulated in a structured consensus process.
RESULTS: Determination of the indication for the admission of COVID-19 patients to the hospital should involve consideration of age, comorbidities, respiratory rate, and oxygen saturation. Every patient admitted without a recent PCR test should be tested immediately. It is recommended that any COVID-19 patient with hypoxemia (SpO2 <90%) despite being given oxygen, dyspnea, or a high respiratory rate be admitted to intensive care. In the case of hypoxemic respiratory insufficiency, an attempt at treatment with high-flow oxygen or non-invasive ventilation is suggested, while patients with severe hypoxemia/high respiratory rate should undergo intubation and invasive ventilation. In the presence of additional risk factors (such as obesity, known thrombophilia, intensive care treatment, or elevated D-dimers), intensified prophylaxis against thromboembolism may be indicated. Treatment with dexamethasone decreases the mortality among patients with severe or critical COVID-19. The important personal protection measures are attention to hygiene and the correct wearing of personal protective equipment.
CONCLUSION: The principal treatment measures are maintenance of adequate oxygenation, pharmacological prevention of thrombosis, and, in severe cases, administration of dexamethasone.
参考来源
- Kluge S, Janssens U, Spinner CD, et al. Clinical Practice Guideline: Recommendations on Inpatient Treatment of Patients with COVID-19. Dtsch Arztebl Int. 2021. PMID: 33531113. doi:10.3238/arztebl.m2021.0110
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。